Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17714
Country/Region: South Sudan
Year: 2016
Main Partner: Johns Hopkins University
Main Partner Program: JHPIEGO
Organizational Type: University
Funding Agency: USAID
Total Funding: $2,019,287 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $72,000
Care: TB/HIV (HVTB) $20,989
Strategic Information (HVSI) $168,000
Health Systems Strengthening (OHSS) $127,899
Prevention: HIV Testing and Counseling (HVCT) $754,573
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $182,923
Treatment: Adult Treatment (HTXS) $679,030
Treatment: Pediatric Treatment (PDTX) $13,873
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 32,008
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 17,275
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,328
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,333
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 51,953
HTC_TST_DSD Service Delivery Point (Community): Index testing 2017 1,122
HTC_TST_DSD Service Delivery Point (Facility): Outpatient 2017 8,544
HTC_TST_DSD Service Delivery Point (Facility): PMTCT 2017 15,454
HTC_TST_DSD Service Delivery Point (Facility): VCT 2017 26,834
HTC_TST_DSD Sum of Aggregated Age/Sex 15+ 2017 49,283
HTC_TST_DSD Sum of Aggregated Age/Sex <15 2017 2,661
HTC_TST_DSD Sum of Aggregated Age/Sex disaggregates 2017 51,944
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 2,404
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,168
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive <15 Female 2017 48
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive <15 Male 2017 48
PMTCT_ART_DSD Already on ART at beginning of current pregnancy 2017 152
PMTCT_ART_DSD New on ART 2017 497
PMTCT_ART_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 15,454
PMTCT_STAT_DSD By: Known positives at entry 2017 160
PMTCT_STAT_DSD By: Number of new positives identified 2017 716
PMTCT_STAT_DSD Number of new ANC and L&D clients 2017 17,062
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 15,454
PMTCT_STAT_DSD Sum of Positives Status disaggregates 2017 876
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 39
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 39
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 98
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 78
TB_SCREENDX_DSD Screen Result: Screened Positive for TB 2017 563
TB_SCREENDX_DSD Screened for TB by Age/Sex: 15+ Female 2017 1,176
TB_SCREENDX_DSD Screened for TB by Age/Sex: 15+ Male 2017 1,200
TB_SCREENDX_DSD Screened for TB by Age/Sex:<15 Female 2017 17
TB_SCREENDX_DSD Screened for TB by Age/Sex:<15 Male 2017 17
TB_SCREENDX_DSD The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 2,409
TB_SCREENDX_DSD [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 545
TB_SCREENDX_DSD [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 506
TB_SCREENDX_DSD [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 64
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 386
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 383
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 769
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2017 962
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2017 2,190
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2017 1,646
TX_CURR_DSD Aggregated Age/Sex: <15 Female 2017 90
TX_CURR_DSD Aggregated Age/Sex: <15 Male 2017 93
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2017 4,199
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2017 3,836
TX_CURR_DSD Sum of Aggregated Age/Sex <15 2017 183
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2017 4,019
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2017 1,819
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2017 1,387
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Female 2017 85
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Male 2017 88
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 3,379
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2017 3,379
Cross Cutting Budget Categories and Known Amounts Total: $300,000
Human Resources for Health $300,000